[15] The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) reviewed this issue in 2023 and did not confirm a causal association between GLP-1 receptor agonists and thyroid cancer in humans
A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction
Seiwerth, S., et al
Prescription medications like tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda), and oral semaglutide (Rybelsus) have shown strong results in suppressing appetite, improving insulin sensitivity, and supporting chronic weight management
Switch over from one food to another should be done gradually by mixing small amounts of both foods during a period of one week
[1] GLP-1 receptor agonists (e.g., semaglutide/Wegovy, liraglutide/Saxenda): These injectable medications mimic the glucagon-like peptide-1 hormone, suppressing appetite and slowing gastric emptying